-+ 0.00%
-+ 0.00%
-+ 0.00%

NovaBridge Biosciences Names Chuck Silberstein CFO

PUBT·10/28/2026 11:06:30
Listen to the news
NovaBridge Biosciences Names Chuck Silberstein CFO
  • NovaBridge Biosciences appointed Chuck Silberstein as chief financial officer, effective November 2, 2026.
  • Silberstein succeeds Kyler Lei, who is stepping down.
  • Previously co-founder and CEO of FytonBio, Silberstein also served as CFO of GentiBio and Applied Therapeutics.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NovaBridge Biosciences published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610280700PRIMZONEFULLFEED9854588) on October 28, 2026, and is solely responsible for the information contained therein.